Biocon Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

600.30

600.30

600.30

600.30

600.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

10,923.20

10,311.10

10,314.80

7,491.70

7,306.20

Loan funds

Secured loans

2,871.00

2,040.80

1,297.70

75.90

-

Unsecured loans

-

-

-

-

-

Total

14,394.50

12,952.20

12,212.80

8,167.90

7,906.20

Uses of funds

Fixed assets

Gross block

2,675.20

2,429.60

2,338.10

2,144.80

1,980.90

Less : revaluation reserve

0.90

0.90

0.90

0.90

0.90

Less : accumulated depreciation

1,561.70

1,471.20

1,376.70

1,274.60

1,182.80

Net block

1,112.60

957.50

960.50

869.30

797.20

Capital work-in-progress

701.30

559.60

343.50

284.90

179.20

Investments

11,382.60

9,318.50

9,270.70

5,280.00

5,412.70

Net current assets

Current assets, loans & advances

2,423.70

2,931.70

2,454.30

2,433.90

2,183.70

Less : current liabilities & provisions

1,225.70

815.10

816.20

700.20

666.60

Total net current assets

1,198.00

2,116.60

1,638.10

1,733.70

1,517.10

Miscellaneous expenses not written

-

-

-

-

-

Total

14,394.50

12,952.20

12,212.80

8,167.90

7,906.20

Notes:

Book value of unquoted investments

9,377.40

7,247.90

7,199.20

2,614.70

2,616.80

Market value of quoted investments

15,428.50

15,475.60

13,096.50

16,871.80

15,346.80

Contingent liabilities

1,081.40

1,125.30

754.80

638.30

1,749.60

Number of equity sharesoutstanding (Lacs)

12006.00

12006.00

12006.00

12006.00

12000.00